Single-use Bioreactors Market Size is Set to Grow to USD 6.7 Billion by 2034 with a CAGR of 10.8% , Driven by Demand in Food and Industrial Biotechnology | Exclusive Report by Transparency Market Research Inc.

Single-use bioreactors are expected to gain traction in the market as customization and sustainability increase.

/EIN News/ -- Wilmington, Delaware, United States, Transparency Market Research, Inc. , Sept. 26, 2024 (GLOBE NEWSWIRE) -- The single-use bioreactors industry (일회용 생물반응기 산업) generated a value of US$ 2.1 billion in 2023. Over the next ten years, the market is expected to expand at a CAGR of 10.8%, reaching 6.7 billion by 2034. Single-use bioreactor operations will be transformed by incorporating digital technologies like IoT, AI, and machine learning into bioprocessing, also known as Bioprocessing 4.0.

Predictive maintenance, process optimization, and quicker decision-making will be made possible by real-time data monitoring and analytics, increasing productivity and cutting expenses.

Single-use bioreactors are expected to find utility in fields other than typical biopharmaceutical manufacturing, like food and beverage production, industrial biotechnology, and agricultural biotechnology. A greater range of companies may be able to afford single-use systems as technology advances and costs come down.

Single-use bioreactor systems that are modular and adjustable will become more in demand as businesses look for ways to be flexible to meet a range of production requirements. Due to their modular architecture, platforms for single-use bioprocessing will be able to easily incorporate extra unit activities, like filtration and purification.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/single-use-bioreactors-market.html

Key Findings of the Market Report

• North America held a majority of the market share in 2023.
• Single-use bioreactor systems are predicted to power market growth.
• Based on cell type, bacterial cells are expected to drive the demand for single-use bioreactors.
• In terms of molecule type, monoclonal antibodies (MABs) will present opportunities in the future.
• As biotechnology companies expand, the market for single-use bioreactors is expected to grow.

Global Single-Use Bioreactors Market: Growth Drivers

• Sterilization and cleaning are expensive with stainless-steel bioreactors but unnecessary with single-use ones. Biopharmaceutical businesses can also save a great deal of money by reducing the possibility of cross-contamination.
• Single-use bioreactors' flexibility and scalability are higher than conventional bioreactors. They are scaled up or down to satisfy production demands and adjusted to various process requirements. Biopharmaceutical businesses can experience huge changes in product demand, which makes this flexibility particularly useful.
• Continuous improvements in single-use bioreactor technology have increased output, dependability, and quality. Advances like disposable mixing systems, sophisticated control systems, and real-time monitoring sensors have increased the versatility of single-use bioreactors and accelerated their acceptance in various applications.
• The growing need for biologics, biosimilars, and gene and cell therapies is fueling the biopharmaceutical industry's continued rapid growth. The widespread usage of single-use bioreactors can be attributed to their cost-effective and efficient solution for generating complicated biopharmaceutical products.
• The FDA and EMA have acknowledged Single-use technology as a major advantage in biopharmaceutical production. As a result of their assistance and guidance in installing single-use solutions, they have further accelerated industry acceptance.

Global Single-Use Bioreactors Market: Regional Landscape

• The biopharmaceutical sector is thriving in North America, which has various biologics, biosimilars, and gene therapy markets. As the biotechnology industry expands and manufacturers seek more flexible and affordable ways to produce their products, single-use bioreactors will become increasingly popular.
• Bioprocessing infrastructure, including manufacturing facilities and research institutions, will improve if single-use bioreactors are implemented. Market expansion will be aided by public and private measures to support the biopharmaceutical industry.
• Health Canada and the FDA in the United States are two regulatory bodies in North America that have backed single-use bioprocessing technologies. The region will adopt single-use bioreactors more easily if there are clear regulatory rules and measures to expedite the clearance process for biologics and innovative medicines.
• Technological innovation and biopharmaceutical research are centered in North America. Prominent educational establishments, research hubs, and biotech hubs to propel advancements in single-use bioreactor technology, promoting cooperation and information sharing among industry participants.
• The increasing focus on personalized medicines and precision medicine in North America will increase the need for biomanufacturing systems that are adaptable and scalable, such as single-use bioreactors. These tools provide the quick and economical creation of personalized treatments according to each patient's requirements.

Global Single-use Bioreactors Market: Key Players

Major market players offer process-optimized products. Microbial bioprocessing requires products well-suited to this process's nuanced demands. Bioprocess control is made more accessible and dependable with budget-friendly single-use bioreactors from key players in the global market.

• Danaher Corporation
• General Electric Company
• Merck KGaA
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Eppendorf AG
• Parker Hannifin Corporation
• PBS Biotech Inc.
• Distek Inc.
• Getinge

Key Developments

• In January 2023, PBS Biotech ("PBS"), a bioreactor manufacturer with single-use technology and process development services, closed a deal valued at $22 million backed by Avego Management, LLC ("Avego") and BroadOak Capital Partners ("BroadOak"). In addition to improving the company's product portfolio, expanding process development capabilities, and increasing customer support for global cell therapy clients, this funding supported the company's expansion and enhancement of its technical support services.
• In August 2023, Sartorius and Repligen merged their technologies to enhance Sartorius' Biostat STR® bioreactor via Repligen's XCell® ATF technology. Both companies believe intensified seed trains and N perfusion are intended to simplify biopharmaceutical manufacturer implementation.

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=2108&ltype=S

Global Single-use Bioreactors Market: Segmentation

By Product Type

• Single-use Bioreactor Systems
• Media Bags
• Filtration Assemblies
• Others

By Cell Type

• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Others

By Molecule Type

• Monoclonal Antibodies (MABs)
• Vaccines
• Stem Cells
• Gene-modified Cells
• Others

By End User

• Biopharmaceutical Companies
• Biotechnology Companies
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

More Trending Reports by Transparency Market Research –

• Tumor Ablation Market - The global tumor ablation market (종양 절제 시장) was projected to attain US$ 1.3 billion in 2022. It is anticipated to garner a 6.9% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ 2.3 billion by 2031.
• Bioprocess Containers Market - The global market for bioprocess containers (바이오프로세스 용기 시장) was estimated to have garnered a global market valuation of around US$ 2.9 billion in 2022. The market is anticipated to grow with a booming 11.1% CAGR from 2022 to 2031 and by 2031, the market is likely to gain US$ 9.3 billion.
• Asia Pacific Single-use Bioprocessing Systems Market – The Asia Pacific single-use bioprocessing systems market (일회용 생물공정 시스템 시장) is expected to increase at a CAGR of 12.50% by 2024.
• ELISA Analyzers Market – The global ELISA analyzers market (ELISA 분석기 시장) is projected to advance at a CAGR of 5.9% from 2023 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube